Skip to main content
. 2017 Feb 23;2017(2):CD012158. doi: 10.1002/14651858.CD012158.pub2

IBV Valve trial 2014.

Methods Randomized clinical trial. 1:1 allocation. Not sufficient information to permit judgement on allocation concealment. Follow‐up until 6 months.
Participants Baseline
Age: treatment 65 years versus control 65 years
Participants: treatment n = 142 versus control n = 135
% female: 43%
Disease distribution: heterogeneous
Baseline score on outcomes:
Mean FEV1 % predicted (SD): treatment 29.8% (7.5) versus control 29.7% (7.9)
Mean QoL in units total score on SGRQ (SD): treatment 54.8 units (15.5) versus control 57.1 units (15.2)
Mean RV % predicted (SD): treatment 216.0% (50.1) versus control 215.8% (55.9)
Mean TLC % predicted (SD): treatment 128.1% (15.9) versus control 128.2% (19.8)
Mean DLCO % predicted (SD): treatment 36.4% (12.7) versus control 35.0% (13.1)
Mean PaO2 in mm Hg (SD): treatment 67.8 mm Hg (11.3) versus control 67.0 mm Hg (10.7)
Mean PaCO2 in mm Hg (SD): treatment 39.8 mm Hg (5.3) versus control 40.8 mm Hg (4.8)
Mean 6MWD in meters (SD): treatment 314.1 m (88.6) versus control 308.6 m (81.6)
Interventions Partial bilateral placement of Intrabronchial valves compared to sham control
Outcomes ‐ St. George Respiratory Questionnaire (SGRQ)
‐ Lobar volume changes
‐ Pulmonary function tests
‐ Short Form‐36
‐ 6‐minute walking distance (6MWD)
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Insufficient information to permit judgement
Allocation concealment (selection bias) Unclear risk Allocation concealment mentioned but not specified
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk " If the patient was randomized to control, a catheter was passed into the target airways and a script read out loud indicating (sham) valve deployment."
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk A separate team without knowledge of the group assignment provided follow‐up evaluations to maintain blinding
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Attrition mentioned: more attrition in treatment group but not deemed sufficient to influence results
Selective reporting (reporting bias) Unclear risk Insufficient information to permit judgement. No protocol published.
Other bias Low risk No other risk of bias found